Impact of the COVID‐19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries

Abstract

The current study highlights the deleterious consequences of the COVID-19 pandemic on the continuity of rheumatology care. Therefore, an action plan, including establishing a telemedicine platform, securing drug availability, and promoting medication persistence through the appropriate communication channels, is strongly recommended.